Research
Hormonal
VLCKD leads to significant improvements in metabolic markers (glucose, lipids, blood pressure) and a notable proportion of patients with mild CKD experience normalization of glomerular filtration rate (eGFR ≥ 90).
For those with mild kidney disease, losing weight via VLCKD may not just preserve but potentially restore kidney function metrics (eGFR) for a significant minority (approx. 28%).
ModerateSupportsMEDIUM confidence
Interestingly, 27.7% of patients with mild renal failure reported normalization of glomerular filtrate after dietary intervention.
Why this rating
Observational data; 'normalization' is a post-hoc observation in a subset.
Source
Very Low-Calorie Ketogenic Diet: A Safe and Effective Tool for Weight Loss in Patients with Obesity and Mild Kidney Failure
Adriano Bruci et al. · Nutrients · 2020
DOI 10.3390/nu12020333
cohort · n=92Cited 185×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →